Chengming Qu
Wuhan University(CN)University of Chicago(US)Zhongnan Hospital of Wuhan University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Nanoplatforms for cancer theranostics, Extracellular vesicles in disease, Immune cells in cancer, MicroRNA in disease regulation
Most-Cited Works
- → Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy(2024)41 cited
- → Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic(2022)36 cited
- → Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity(2024)19 cited
- → A Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma ≤ 5 cm(2022)18 cited
- → Percutaneous ultrasound-guided ‘three-step’ radiofrequency ablation for giant hepatic hemangioma (5–15 cm): a safe and effective new technique(2020)16 cited
- → Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy(2025)12 cited
- → The Short-Term Efficacy of Novel No-Touch Combined Directional Perfusion Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma with Cirrhosis(2021)10 cited
- → Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma(2021)8 cited
- → Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression(2025)4 cited
- → Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma(2025)3 cited